INNO-LiPA® HPV Genotyping Extra II
Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).
Fujirebio is global R&D-driven company constantly developing new in vitro diagnostics testing technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe, and the US focus on delivering products with the highest quality standards to our customers and partners. We value CDMO partnerships with many of the world’s leading diagnostic companies, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms.
Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).
Qualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.
Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18...
Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.
Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.
Fujirebio is global R&D-driven company constantly developing new in vitro diagnostics testing technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe, and the US focus on delivering products with the highest quality standards to our customers and partners. We value CDMO partnerships with many of the world’s leading diagnostic companies, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms.